NOT FOR REPRINT
Page Printed from: benefitspro.com/author/profile/tim-loh/
Sign In To follow
With flu and COVID hospital admission rates now mirroring each other, Novavax, which lost out in the COVID vaccine race to Pfizer and Moderna, signed a licensing agreement with Sanofi to commercialize a combined COVID-flu shot.